Abstract:Synergistic therapy that combines chemo-, gene-, or photothermal means shows great potential for enhancing the therapeutic effects on cancers. Tumor-targeted nanoparticles based on a doxorubicin (DOX)-gated mesoporous silica nanocore (MSN) encapsulated with permeability glycoprotein (P-gp) small interfering RNA (siRNA) and a polydopamine (PDA) outer layer for DOX loading and folic acid decoration are designed. The multifunctional nanoplatform tactfully integrates chemo-(DOX), gene-(P-gp siRNA), and phototherma… Show more
“…36,37 For instance, doxorubicin has been designed to form stimuli-responsive nanoplatform using mesoporous silica nanomaterial with benzoic-imine bond, which upon cleavage in the acidic tumor environment, release DOX and other drug, which express better antitumor therapeutic efficiency in vitro and in vivo. 38,39 Here, we successfully synthesized pH-responsive materials 4-arm-PEG-DTX with hydrazone bonds (Fig. 1) and used it to encapsulate DHA to prepare pHsensitive D/D NPs (Fig.…”
“…36,37 For instance, doxorubicin has been designed to form stimuli-responsive nanoplatform using mesoporous silica nanomaterial with benzoic-imine bond, which upon cleavage in the acidic tumor environment, release DOX and other drug, which express better antitumor therapeutic efficiency in vitro and in vivo. 38,39 Here, we successfully synthesized pH-responsive materials 4-arm-PEG-DTX with hydrazone bonds (Fig. 1) and used it to encapsulate DHA to prepare pHsensitive D/D NPs (Fig.…”
“…Xenograft Tumor Model : The MCF‐7 cell xenograft tumor model was performed according to a previous method . All the protocols for the proposed in vivo experiments were approved by the Administrative Committee on Animal Research in the Tsinghua University.…”
Multifunctional nanomaterials with efficient tumor-targeting and high antitumor activity are highly anticipated in the field of cancer therapy. In this work, a synergetic tumor-targeted, chemo-photothermal combined therapeutic nanoplatform based on a dynamically PEGylated, borate-coordination-polymer-coated polydopamine nanoparticle (PDA@CP-PEG) is developed. PEGylation on the multifunctional nanoparticles is dynamically achieved via the reversible covalent interaction between the surface phenylboronic acid (PBA) group and a catechol-containing poly(ethylene glycol) (PEG) molecule. Due to the acid-labile PBA/catechol complex and the weak-acid-stable PBA/sialic acid (SA) complex, the nanoparticles can exhibit a synergetic targeting property for the SA-overexpressed tumor cells, i.e., the PEG-caused "passive targeting" and PBA-triggered "active targeting" under the weakly acidic tumor microenvironment. In addition, the photothermal effect of the polydopamine core and the doxorubicin-loading capacity of the porous coordination polymer layer endow the nanoparticles with the potential for chemo-photothermal combination therapy. As expected, the in vitro and in vivo studies both verify that the multifunctional nanoparticles possess relatively lower systematic toxicity, efficient tumor targeting ability, and excellent chemo-photothermal activity for tumor inhibition. It is believed that these multifunctional nanoparticles with synergetic tumor targeting property and combined therapeutic strategies would provide an insight into the design of a high-efficiency antitumor nanoplatform for potential clinical applications.
“…Metal-organic framework (MOF), as a new class of hybrid materials, consists of inorganic building units covalently connected by organic building units. [43] Porphyrin-based MOF that have been developed so far for potential PDT outcome, however, almost all of them are compounded with other nanoparticles to form new compounds for synergistic treatment (such as PDT-PTT, PDT-Radiation therapy), [44] the complex structures would reduce the clinical medical value. [41,42] Porphyrins and porphyrin derivatives as photosensitizers are hydrophobic in nature, which not only cause insufficient selectivity to the site of tumor, but also leads to PS polymerization, reducing the efficacy of PDT and making it very attractive for the assembly structure of organic building units of MOF.…”
Hypoxic tumor microenvironment is the bottleneck of the conventional photodynamic therapy (PDT) and significantly weakens the overall therapeutic efficiency. Herein, versatile metal–organic framework (MOF) nanosheets (DBBC‐UiO) comprised of bacteriochlorin ligand and Hf
6
(µ
3
‐O)
4
(µ
3
‐OH)
4
clusters to address this tricky issue are designed. The resulting DBBC‐UiO enables numerous superoxide anion radical (O
2
−•
) generation via a type I mechanism with a 750 nm NIR‐laser irradiation, part of which transforms to high toxic hydroxyl radical (OH•) and oxygen (O
2
) through superoxide dismutase (SOD)‐mediated catalytic reactions under severe hypoxic microenvironment (2% O
2
), and the partial recycled O
2
enhances O
2
−•
generation. Owing to the synergistic radicals, it realizes advanced antitumor performance with 91% cell mortality against cancer cells in vitro, and highly efficient hypoxic solid tumor ablation in vivo. It also accomplishes photoacoustic imaging (PAI) for cancer diagnosis. This DBBC‐UiO, taking advantage of superb penetration depth of the 750 nm laser and distinct antihypoxia activities, offers new opportunities for PDT against clinically hypoxic cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.